Jefferies Upgrades CytomX Therapeutics (CTMX) to Buy

March 23, 2021 6:15 AM EDT
Get Alerts CTMX Hot Sheet
Price: $7.45 -0.8%

Rating Summary:
    12 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 20 | New: 67
Trade Now! 
Join SI Premium – FREE

Jefferies analyst Roger Song upgraded CytomX Therapeutics (NASDAQ: CTMX) from Hold to Buy with a price target of $14.00 (from $9.00).


For an analyst ratings summary and ratings history on CytomX Therapeutics click here. For more ratings news on CytomX Therapeutics click here.


Shares of CytomX Therapeutics closed at $8.52 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades